Sunway Healthcare Holdings Bhd (KL:SUNMED), which listed on Bursa Malaysia in 2025, has seen its stock retreat approximately 30% from its initial peak. The company, a private healthcare operator, had a market capitalization of around RM 8 billion at its peak.
Analysts are divided on whether the current price represents a buying opportunity. Some cite the company's strong fundamentals, including a network of hospitals and a growing patient base, while others point to high valuation multiples relative to peers like IHH Healthcare Bhd.
The Edge Malaysia Weekly, in its June 15-21, 2026 edition, noted that SunMed's price-to-earnings ratio remains above the sector average. The company's revenue growth has been steady, but profit margins have been under pressure from rising operational costs.
